Thermo Fisher Scientific's $13.6 Billion Acquisition of Life Technologies Boosts Flagging M&A Numbers May 01, 2013 | Press Release
Burrill Securities Launches Institutional Breakthrough Series April 29, 2013 | Press Release
Big Biotech Outpaces Big Pharma, Burrill & Company says April 16, 2013 | Press ReleaseSee all News
Burrill's venture funds capitalize on our unique investment platform, the opportunities created by today’s technologic revolution, and capital market inefficiency.
Learn more about Burrill Venture Capital
Burrill's Institutional Equities business provides capital markets expertise.
Learn more about Burrill Institutional Equities
Burrill Merchant Banking assists life science companies identify, negotiate and close strategic partnerships, M&A transactions and financings.
Learn more about Burrill Merchant Banking
Burrill & Company has established a multicultural and multilingual team, with extensive international business experience, to bridge the different regions of the world.
Learn more about Burrill International
Burrill Conferences & Special Events